33 Results | Sars-Cov-2 | Search

Displaying 1 - 25 of 33 Results

SARS-CoV-2 M^pro Protein

Active • Host: E. coli • AA: 1-306 of SARS-CoV-2 M^pro Protein (full length), 3,264-3,569 of P0DTD1 • MW: 33.9 kDa

Item No. 30588

Formulation: 20 mM HEPES, pH 7.5, with 2.5 mM DTT and 10% glycerol

Purity: ≥95% estimated by SDS-PAGE

3C-like Proteinase
Coronavirus Endopeptidase C30
Peptidase C30
Severe Acute Respiratory Syndrome Coronavirus 2 M^pro

100 µg

$423

Add

SARS-CoV-2 Nucleocapsid Protein

Host: HEK293 cells • AA: 1-419 (full length) • Tag: C-terminal DYKDDDDK • MW: 49.7 kDa

Item No. 30427

Purity: ≥90% estimated by SDS-PAGE

2019-nCoV NP
2019-nCoV Nucleocapsid Protein
2019-nCoV Nucleoprotein
COVID-19 NP
COVID-19 Nucleocapsid Protein
COVID-19 Nucleoprotein
SARS-CoV-2 NP
SARS-CoV-2 Nucleoprotein
Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein

50 µg

$1,095

Add

SARS-CoV-2 Papain-like Protease (recombinant)

Active • Host: E. coli • AA: 1,564-1,880 • Tag: N-terminal His • MW: 36.8 kDa

Item No. 31817

Formulation: Lyophilized from sterile 20 mM Tris, pH 7.4, with 500 mM sodium chloride

Purity: ≥90% estimated by SDS-PAGE

2019-nCoV PL^pro
COVID-19-PL^pro
SARS-CoV-2 PL^pro
Severe Acute Respiratory Syndrome Coronavirus 2 Papain-like Protease

100 µg

$543

Add

SARS-CoV-2 nsp9 (recombinant)

Host: E. coli • AA: 1-113 • Tag: N-terminal His and C-terminal AVI • MW: 15.5 kDa

Item No. 31978

Formulation: Lyophilized from sterile 50 mM Tris, pH 7.4, with 150 mM NaCl, and 2 mM βME

Purity: ≥90% as determined by SDS-PAGE

2019-nCoV nsp9
COVID-19 nsp9
Severe Acute Respiratory Syndrome Coronavirus 2 nsp9

100 µg

$543

Add

SARS-CoV-2 nsp8 (recombinant)

Host: E. coli • AA: 1-198 • Tag: N-Terminal His and DYKDDK

Item No. 40882

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

Severe Acute Respiratory Syndrome Coronavirus 2 nsp8
SARS-CoV-2 Non-structural Protein 8

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 nsp7 (recombinant)

Host: E. coli • AA: 3,831-3,913 • Tag: C-terminal His

Item No. 40881

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

SARS-CoV-2 Non-structural Protein 7
Severe Acute Respiratory Syndrome Coronavirus 2 nsp7

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 nsp4 (recombinant)

Host: E. coli • AA: 405-500 • Tag: N-terminal GST

Item No. 40880

Formulation: 50 mM Tris, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

SARS-CoV-2 Non-structural Protein 4
Severe Acute Respiratory Syndrome Coronavirus 2 nsp4

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 nsp10 (recombinant)

Host: E. coli • AA: 1-139 (full length) • Tag: N-terminal His

Item No. 40883

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

SARS-CoV-2 Non-structural Protein 10
Severe Acute Respiratory Syndrome Coronavirus 2 nsp10

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 nsp1 (recombinant)

Host: E. coli • AA: 13-128 • Tag: N-Terminal His

Item No. 40879

Formulation: 50 mM Tris-HCl, pH 7.5, 200 mM sodium chloride, and 20% glycerol

Purity: ≥90%

SARS-CoV-2 Host Translation Inhibitor nsp1
SARS-CoV-2 Non-structural Protein 1
Severe Acute Respiratory Syndrome Coronavirus 2 nsp1

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 nsp16 Methyltransferase (recombinant)

Host: E. coli • AA: 6799-7096 • Tag: C-terminal His • MW: 33.46 kDa

Item No. 31816

Formulation: Lyophilized from sterile 20mM Tris 150mM sodium chloride, pH 8.3, with 5% trehalose, 5% mannitol, and 0.01% tween-80

Purity: ≥85% as determined by SDS-PAGE

2019-nCoV nsp16
2'-O-MTase, ME, nsp16, 2'-O-methyltransferase, SARS-CoV-2 nsp16
SARS-CoV-2 nsp16
Severe Acute Respiratory Syndrome Coronavirus 2 nsp16 Methyltransferase

100 µg

$543

Add

SARS-CoV-2 nsp14 Methyltransferase (recombinant)

Host: E. coli • AA: 1-527 (full length) • Tag: N-terminal GST • MW: 86.3 kDa

Item No. 40884

Formulation: 50 mM Tris, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

SARS-CoV-2 Guanine-N7 Methyltransferase
SARS-CoV-2 Guanine-N7 MTase
SARS-CoV-2 Non-structural Protein 14
Severe Acute Respiratory Syndrome Coronavirus 2 nsp14 Methyltransferase

100 µg

$601

Add

500 µg

$1,947

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Motif

AA: 438-506 • Tag: N-terminal biotin labeling • MW: 8.053 kDa

Item No. 30428

Formulation: A solid

Purity: ≥95%

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Motif

1 mg

$1,467

Add

SARS-CoV-2 Spike Glycoprotein (433-506)

AA: 433-506 • MW: 8.41 kDa

Item No. 30430

Purity: ≥95%

SARS-CoV-2 Surface Glycoprotein
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein

1 mg

$1,467

Add

SARS-CoV-2 nsp13 Helicase (E. coli expressed)

Active • Host: E. coli • AA: 5325-5925 • MW: 69.1 kDa

Item No. 30589

Formulation: 50 mM Tris-HCl, pH 7.5, with 5 µM zinc chloride, 1 mM DTT, 1 mM EDTA, and 15% glycerol

Purity: ≥70% estimated by SDS-PAGE

2019-nCOV Helicase
COVID-19 Helicase
NSP13
SARS-CoV-2 Helicase, COVID19 Helicase
Severe Acute Respiratory Syndrome Coronavirus 2 nsp13 Helicase

10 µg

$369

Add

SARS-CoV-2 Spike Glycoprotein S2 Subunit (recombinant)

Host: Insect cells • AA: 686-1,213 • Tag: C-terminal mouse IgG1 Fc • MW: 84.33 kDa

Item No. 31815

Formulation: Lyophilized from sterile 20 mM Tris, pH 7.0, 300 mM sodium chloride, and 100 mM glycine

Purity: ≥95% estimated by SDS-PAGE

2019-nCoV Surface Glycoprotein S2 Subunit
COVID-19 Spike Glycoprotein S2 Subunit
SARS-CoV-2 Spike Glycoprotein S2 Subunit
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein S2 Subunit

100 µg

$543

Add

SARS-CoV-2 Spike Glycoprotein S1 Subunit (recombinant)

Active • Host: HEK293 cells • Tag: C-terminal mouse IgG1 Fc • AA: 16-685 • MW: 101.4 kDa

Item No. 31814

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

COVID-19 Surface Glycoprotein S1 Subunit
2019-nCoV Surface Glycoprotein S1 Subunit
SARS-CoV-2 Surface Glycoprotein S1 Subunit
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein S1 Subunit

100 µg

$543

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain (human IgG1 Fc-tagged)

Host: HEK293 cells • AA: 319-541 • Tag: C-terminal human IgG1 Fc • MW: 52.3 kDa

Item No. 30429

Formulation: 1 mg/ml in a solution of PBS, pH 7.2

Purity: ≥90% estimated by SDS-PAGE

SARS-CoV-2 Surface Receptor Binding Domain
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain

50 µg

$1,201

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain (rabbit IgG1 Fc-tagged)

Active • Host: HEK293 cells • AA: 319-541 • Tag: C-terminal rabbit IgG1 Fc • MW: 50.3 kDa

Item No. 30590

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% Tween 20, and 10% glycerol

Purity: ≥85%

SARS-CoV-2 Spike Receptor Binding Domain
S1 RBD
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain
Spike S1 RBD

100 µg

$623

Add

SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant; recombinant)

Host: E. coli • AA: 1-475 (full length) • Tag: N-terminal His and MBP • MW: 52.2 kDa

Item No. 40875

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

SARS-CoV-2 E Protein
SARS-CoV-2 Envelope Small Membrane Protein
SARS-CoV-2 sM Protein
Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Protein

100 µg

$493

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain (recombinant; aa 21-243, 319-541) (His-tagged)

Active • Host: HEK293 cells • AA: 21-243, 319-541 of P0DTC2 • Tag: C-terminal His • MW: 28.7 kDa

Item No. 32571

Formulation: PBS, pH 7.4, with 5% mannitol, 0.01% Tween 20, and 10% glycerol

Purity: ≥90%

SARS-CoV-2 Spike RBD
SARS-CoV-2 Spike Receptor Binding Domain
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain
Spike S1 RBD

100 µg

$623

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain N501Y variant (rabbit IgG1 Fc-tagged)

Active • Host: HEK293 cells • AA: 21-243, 319-541 • Tag: C-terminal rabbit IgG1 Fc • MW: 50.37 kDa

Item No. 33867

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% polysorbate 20, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

SARS-CoV-2 Spike RBD
SARS-CoV-2 Spike Receptor Binding Domain
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain
Spike S1 RBD
UK Variant
WHO Label: Alpha

100 µg

$623

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain L452R, T478K variant (rabbit IgG1 Fc-tagged)

Active • Host: HEK293 cells • AA: 21-243, 319-541 • Tag: C-terminal rabbit IgG1 Fc • MW: 50.4 kDa

Item No. 34837

Formulation: PBS, pH 7.4, with 5% mannitol, 5% D-(+)-trehalose, 0.01% Tween 20, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

Delta Variant
SARS-CoV-2 Spike RBD
SARS-CoV-2 Spike Receptor Binding Domain
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain
Spike S1 RBD

100 µg

$623

Add

SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain K417N, E484K, N501Y variant (rabbit IgG1 Fc-tagged)

Active • Host: HEK293 cells • AA: 21-243, 319-541 • Tag: C-terminal rabbit IgG1 Fc • MW: 50.35 kDa

Item No. 33868

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% polysorbate 20, and 10% glycerol

Purity: ≥90% (estimated by SDS-PAGE)

SARS-CoV-2 Spike RBD
SARS-CoV-2 Spike Receptor Binding Domain
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain
South African Variant
Spike S1 RBD
WHO Label: Beta

100 µg

$623

Add

BRD4 bromodomains 1 and 2 (human, recombinant; aa 49-460)

Host: E. coli • AA: 49-460 • Tag: N-terminal GST • MW: 73.4 kDa

Item No. 11052

Formulation: 50 mM Hepes, pH 7.5, with 500 mM sodium chloride, 5% glycerol, and 5 mM β-mercaptoethanol

Purity: ≥65% estimated by SDS-PAGE

BRD4
Bromodomain containing protein 4
HUNK1
MCAP

100 µg

$401

Add

BRD4 bromodomain 1 (human, recombinant; GST-tagged)

Host: E. coli • AA: 49-170 • Tag: N-terminal GST • MW: 41.4 kDa

Item No. 11068

Formulation: 50 mM HEPES, pH 7.5, with 500 mM sodium chloride, 5 mM β-mercaptoethanol, and 5% glycerol

Purity: ≥95% estimated by SDS-PAGE

BRD4 BD1
Bromodomain containing protein 4
HUNK1
MCAP

100 µg

$382

Add

Displaying 1 - 25 of 33 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: 20 mM HEPES, pH 7.5, with 2.5 mM DTT and 10% glycerol

Purity: ≥95% estimated by SDS-PAGE

Purity: ≥90% estimated by SDS-PAGE

Formulation: Lyophilized from sterile 20 mM Tris, pH 7.4, with 500 mM sodium chloride

Purity: ≥90% estimated by SDS-PAGE

Formulation: Lyophilized from sterile 50 mM Tris, pH 7.4, with 150 mM NaCl, and 2 mM βME

Purity: ≥90% as determined by SDS-PAGE

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

Formulation: 50 mM Tris, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90%

Formulation: 50 mM Tris-HCl, pH 7.5, 200 mM sodium chloride, and 20% glycerol

Purity: ≥90%

Formulation: Lyophilized from sterile 20mM Tris 150mM sodium chloride, pH 8.3, with 5% trehalose, 5% mannitol, and 0.01% tween-80

Purity: ≥85% as determined by SDS-PAGE

Formulation: 50 mM Tris, pH 7.5, with 200 mM sodium chloride and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

Formulation: A solid

Purity: ≥95%

Purity: ≥95%

Formulation: 50 mM Tris-HCl, pH 7.5, with 5 µM zinc chloride, 1 mM DTT, 1 mM EDTA, and 15% glycerol

Purity: ≥70% estimated by SDS-PAGE

Formulation: Lyophilized from sterile 20 mM Tris, pH 7.0, 300 mM sodium chloride, and 100 mM glycine

Purity: ≥95% estimated by SDS-PAGE

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

Formulation: 1 mg/ml in a solution of PBS, pH 7.2

Purity: ≥90% estimated by SDS-PAGE

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% Tween 20, and 10% glycerol

Purity: ≥85%

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

Formulation: PBS, pH 7.4, with 5% mannitol, 0.01% Tween 20, and 10% glycerol

Purity: ≥90%

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% polysorbate 20, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

Formulation: PBS, pH 7.4, with 5% mannitol, 5% D-(+)-trehalose, 0.01% Tween 20, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

Formulation: PBS, pH 7.4, with 5% mannitol, 5% trehalose, 0.01% polysorbate 20, and 10% glycerol

Purity: ≥90% (estimated by SDS-PAGE)

Formulation: 50 mM Hepes, pH 7.5, with 500 mM sodium chloride, 5% glycerol, and 5 mM β-mercaptoethanol

Purity: ≥65% estimated by SDS-PAGE

Formulation: 50 mM HEPES, pH 7.5, with 500 mM sodium chloride, 5 mM β-mercaptoethanol, and 5% glycerol

Purity: ≥95% estimated by SDS-PAGE